- Author:
Boyoung JOUNG
1
;
Jung Myung LEE
;
Ki Hong LEE
;
Tae Hoon KIM
;
Eue Keun CHOI
;
Woo Hyun LIM
;
Ki Woon KANG
;
Jaemin SHIM
;
Hong Euy LIM
;
Junbeom PARK
;
So Ryoung LEE
;
Young Soo LEE
;
Jin Bae KIM
;
Author Information
- Publication Type:Review
- Keywords: Atrial fibrillation; Guideline; Anticoagulants; Therapy
- MeSH: American Heart Association; Anticoagulants; Arrhythmias, Cardiac; Asia; Atrial Fibrillation; Cardiology; Consensus; Heart; Humans; Mass Screening; Risk Factors; Stroke
- From:Korean Circulation Journal 2018;48(12):1033-1080
- CountryRepublic of Korea
- Language:English
- Abstract: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general population. The Korean Heart Rhythm Society organized a Korean AF Management Guideline Committee and analyzed all available studies regarding the management of AF, including studies on Korean patients. This guideline is based on recent data of the Korean population and the recent guidelines of the European Society of Cardiology, European Association for Cardio-Thoracic Surgery, American Heart Association, and Asia Pacific Heart Rhythm Society. Expert consensus or guidelines for the optimal management of Korean patients with AF were achieved after a systematic review with intensive discussion. This article provides general principles for appropriate risk stratification and selection of anticoagulation therapy in Korean patients with AF. This guideline deals with optimal stroke prevention, screening, rate and rhythm control, risk factor management, and integrated management of AF.